Christina Willwerth

Insider Reports History

Entity
Individual
Location
C/O Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington, MA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christina Willwerth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Chief Strategy Officer Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Chief Strategy Officer Stock Option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Christina Willwerth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FLXN Flexion Therapeutics Inc Nov 19, 2021 11 -$1.2M 4 Nov 19, 2021 Chief Strategy Officer
FLXN Flexion Therapeutics Inc Jul 19, 2021 1 -$25.4K 4 Jul 20, 2021 Chief Strategy Officer